CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
Ferrous Sulfatedietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03706638
NCT03706638N/ACompleted

Daily vs. Intermittent Iron Therapy in Iron Deficient Pregnant Patients: A Randomized Noninferiority Trial

UConn Health·interventional·Posted Oct 16, 2018·Updated Apr 21, 2020

In Brief

A clinical study evaluating Ferrous Sulfate for Iron Deficiency Anemia of Pregnancy. Completed, enrolled 46 participants across 1 site.

Detailed Summary

This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin receptor). The secondary outcome is to evaluate gastrointestinal discomfort and adherence to therapy between two treatment groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 16, 2018
Enrollment StartOct 25, 2018
Primary CompletionMar 23, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.7 years ago

Interventions

Ferrous Sulfatedietary

Patients would be randomized to either taking ferrous sulfate daily or every other day (on non consecutive days).